Medical device firm Sight Sciences debuts IPO

Sight Sciences, a medical device company, has gone public after pricing its 10 million shares at $24 per share.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this